ESTRO 2024 - Abstract Book

S2772

Interdisciplinary - Health economics & health services research

ESTRO 2024

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.

Rosenblatt E. Planning national radiotherapy services. Front Oncol. 2014;4:315.

596

Mini-Oral

The utilisation of brachytherapy in Europe – A BrachyHERO survey

Jacob G Johansen 1,2 , Ina-Maria Jürgenliemk-Schulz 3 , Hathal Haddad 4 , Jean-Michel Hannoun-Levi 5 , Taran Hellebust 6 , Benjamin Guix 7 , Kristina Lössl 8 , Bradley R Pieters 9,10 , Christopher Rao 11,12 , Vratislav Strnad 13 , Alina E Sturdza 14 , Luca Tagliaferri 15 , Zoltán Takácsi-Nagy 16 , Elena Villafranca 17 , Piotr Wojcieszek 18 , Agata Rembielak 19,20 , Peter Niehoff 21 1 Aarhus University, Department of clinical Medicine, Aarhus, Denmark. 2 Aarhus University Hospital, Danish Centre for Particle Therapy, Aarhus, Denmark. 3 UMCU, Radiation Oncology, Utrecht, Netherlands. 4 Tuebingen University Hospital and medical faculty, Eberhard Karls University of Tübingen, Department of Radiation Oncology, Tübingen, Germany. 5 Antoine Lacassagne Cancer Center, Radiation Oncology, Nice, France. 6 Oslo University Hospital, Department of Medical Physics, Oslo, Norway. 7 Fundación IMOR, ATRYS, Radiation Oncology, Barcelona, Spain. 8 Inselspital, Bern University Hospital, University of Bern, Clinic of Radiation Oncology, Bern, Switzerland. 9 Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, Netherlands. 10 University of Amsterdam, dept. of Radiation Oncology, Amsterdam, Netherlands. 11 Imperial College London, Surgery and Cancer, London, United Kingdom. 12 Cumberland Infirmary, Colorectal Surgery, Carlisle, United Kingdom. 13 University Hospital Erlangen, Department of Radiation Oncology, Erlangen, Germany. 14 Medical University of Vienna, Radiation Oncology, Vienna, Austria. 15 Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Radiotherapy, Rome, Italy. 16 National Institute of Oncology and Semmelweis University, Radiotherapy, Budapest, Hungary. 17 Hospital Universitario de Navarra, Radiation Oncology, Pamplona, Spain. 18 MSC National Research Institute of Oncology, Gliwice branch, Brachytherapy Department, Gliwice, Poland. 19 The Christie NHS Foundation Trust, Clinical Oncology, Manchester, United Kingdom. 20 The University of Manchester, Division of Cancer Sciences | School of Medical Sciences | Faculty of Biology, Medicine and Health, Manchester, United Kingdom. 21 Sana Kliniken Offenbach, Dep. Of Radiotherapy, Offenbach, Germany

Purpose/Objective:

BrachyHERO (Brachytherapy Health Economics in Radiation Oncology) was established in 2017 with the aim of providing an up-to-date status of brachytherapy practice in Europe and investigate its future role. As a first step, a survey was conducted to inquire about the general utilisation of brachytherapy in Europe and about the individual national structures pertinent to this treatment.

Material/Methods: